Koers Avinger Inc Nasdaq
Aandelen
US0537342083
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 10,5 mln. 9,75 mln. | Omzet 2025 * | 13,93 mln. 12,95 mln. | Marktkapitalisatie | 6,19 mln. 5,75 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -16 mln. -14,87 mln. | Nettowinst (verlies) 2025 * | -14 mln. -13,01 mln. | EV/omzet 2024 * | 0,59 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,44 x |
K/w-verhouding 2024 * |
-1,88
x | K/w-verhouding 2025 * |
-2,89
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 84,15% |
Recentste transcriptie over Avinger Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Himanshu Patel
FOU | Founder | 63 | 08-03-07 |
Jeffrey Soinski
CEO | Chief Executive Officer | 61 | 29-12-14 |
Nabeel Subainati
DFI | Director of Finance/CFO | 41 | 01-01-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jeffrey Soinski
CEO | Chief Executive Officer | 61 | 29-12-14 |
James Cullen
CHM | Chairman | 81 | 01-12-14 |
James McElwee
BRD | Director/Board Member | 72 | 01-03-11 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,25% | 15,01 mld. | |
-38,91% | 2,8 mld. | |
-12,68% | 2,45 mld. | |
-12,18% | 1,46 mld. | |
-.--% | 1,12 mld. | |
+46,70% | 534 mln. | |
+14,96% | 245 mln. | |
-13,03% | 203 mln. | |
+2,59% | 187 mln. |